270 related articles for article (PubMed ID: 1318035)
1. Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Effects of monoclonal antibodies to t-PA.
Otter M; Kuiper J; Bos R; Rijken DC; van Berkel TJ
Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):545-50. PubMed ID: 1318035
[TBL] [Abstract][Full Text] [Related]
2. Cluster mannosides can inhibit mannose receptor-mediated tissue-type plasminogen activator degradation by both rat and human cells.
Noorman F; Barrett-Bergshoeff MM; Biessen EA; van de Bilt E; van Berkel TJ; Rijken DC
Hepatology; 1997 Nov; 26(5):1303-10. PubMed ID: 9362376
[TBL] [Abstract][Full Text] [Related]
3. Clearance of tissue plasminogen activator by mannose and galactose receptors in the liver.
Smedsrød B; Einarsson M
Thromb Haemost; 1990 Feb; 63(1):60-6. PubMed ID: 2160132
[TBL] [Abstract][Full Text] [Related]
4. Receptor-mediated endocytosis of ovalbumin by two carbohydrate-specific receptors in rat liver cells. The intracellular transport of ovalbumin to lysosomes is faster in liver endothelial cells than in parenchymal cells.
Kindberg GM; Magnusson S; Berg T; Smedsrød B
Biochem J; 1990 Aug; 270(1):197-203. PubMed ID: 2396980
[TBL] [Abstract][Full Text] [Related]
5. Tissue plasminogen activator is endocytosed by mannose and galactose receptors of rat liver cells.
Smedsrød B; Einarsson M; Pertoft H
Thromb Haemost; 1988 Jun; 59(3):480-4. PubMed ID: 2847350
[TBL] [Abstract][Full Text] [Related]
6. Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo.
Narita M; Bu G; Herz J; Schwartz AL
J Clin Invest; 1995 Aug; 96(2):1164-8. PubMed ID: 7635954
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
Sitter T; Toet K; Quax P; Kooistra T
Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the interaction in vivo of tissue-type plasminogen activator with liver cells.
Kuiper J; Otter M; Rijken DC; van Berkel TJ
J Biol Chem; 1988 Dec; 263(34):18220-4. PubMed ID: 3142872
[TBL] [Abstract][Full Text] [Related]
9. Evidence for carbohydrate-independent endocytosis of tissue-type plasminogen activator by liver cells.
Stang E; Roos N; Schlüter M; Berg T; Krause J
Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):799-804. PubMed ID: 1323274
[TBL] [Abstract][Full Text] [Related]
10. Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cells.
Rijken DC; Otter M; Kuiper J; van Berkel TJ
Thromb Res Suppl; 1990; 10():63-71. PubMed ID: 2107599
[TBL] [Abstract][Full Text] [Related]
11. Degradation of tissue-type plasminogen activator by human monocyte-derived macrophages is mediated by the mannose receptor and by the low-density lipoprotein receptor-related protein.
Noorman F; Braat EA; Rijken DC
Blood; 1995 Nov; 86(9):3421-7. PubMed ID: 7579446
[TBL] [Abstract][Full Text] [Related]
12. Receptor-mediated endocytosis of tissue-type plasminogen activator by low density lipoprotein receptor-related protein on human hepatoma HepG2 cells.
Bu G; Maksymovitch EA; Schwartz AL
J Biol Chem; 1993 Jun; 268(17):13002-9. PubMed ID: 8389767
[TBL] [Abstract][Full Text] [Related]
13. The interaction of recombinant tissue type plasminogen activator and recombinant plasminogen activator (r-PA/BM 06.022) with human endothelial cells.
Mulder M; Kohnert U; Fischer S; van Hinsbergh VW; Verheijen JH
Blood Coagul Fibrinolysis; 1997 Mar; 8(2):124-33. PubMed ID: 9518044
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies against the human mannose receptor that inhibit the binding of tissue-type plasminogen activator.
Barrett-Bergshoeff M; Noorman F; Bos R; Rijken DC
Thromb Haemost; 1997 Apr; 77(4):718-24. PubMed ID: 9134649
[TBL] [Abstract][Full Text] [Related]
15. Role of carbohydrate and protein in the binding of tissue-type plasminogen activator to the human mannose receptor.
Noorman F; Barrett-Bergshoeff MM; Rijken DC
Eur J Biochem; 1998 Jan; 251(1-2):107-13. PubMed ID: 9492274
[TBL] [Abstract][Full Text] [Related]
16. Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells.
van der Kaaden ME; Rijken DC; Groeneveld E; van Berkel TJ; Kuiper J
Thromb Haemost; 1995 Aug; 74(2):722-9. PubMed ID: 8585013
[TBL] [Abstract][Full Text] [Related]
17. Identification and partial characterization by chemical cross-linking of a binding protein for tissue-type plasminogen activator (t-PA) on rat hepatoma cells. A plasminogen activator inhibitor type 1-independent t-PA receptor.
Bu G; Morton PA; Schwartz AL
J Biol Chem; 1992 Aug; 267(22):15595-602. PubMed ID: 1322401
[TBL] [Abstract][Full Text] [Related]
18. Binding and degradation of tissue-type plasminogen activator by the human hepatoma cell line Hep G2.
Otter M; Van Berkel TJ; Rijken DC
Thromb Haemost; 1989 Sep; 62(2):667-72. PubMed ID: 2510347
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of mannose receptor-mediated clearance of tissue-type plasminogen activator (t-PA) by dextran: a new explanation for its antithrombotic effect.
Noorman F; Barrett-Bergshoeff MM; Bekkers M; Emeis JJ; Rijken DC
Thromb Haemost; 1997 Oct; 78(4):1249-54. PubMed ID: 9364993
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the interaction of a complex of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 with rat liver cells.
Kuiper J; Otter M; Voorschuur AH; van Zonneveld AJ; Rijken DC; van Berkel TJ
Thromb Haemost; 1995 Nov; 74(5):1298-304. PubMed ID: 8607113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
